This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Severn Trent PLC | 2574 | 0.94% |
| Imperial Brands PLC | 2572 | 0.55% |
| Hikma Pharmaceuticals PLC | 1935 | 0.36% |
| Diageo PLC | 2525.50 | 0.28% |
| Admiral Group PLC | 2614 | 0.19% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Pershing Square Holdings LTD | 3732 | -3.76% |
| Mondi PLC | 1145.50 | -3.66% |
| Ashtead Group PLC | 4990 | -3.41% |
| Marks & Spencer Group PLC | 378.20 | -3.40% |
| British Land Company PLC | 351.6 | -3.35% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 8,105 | -1.1% | 5.1% |
| DOW JONES INDUS. AVG | 42,342 | 0.0% | 14.2% |
| DAX INDEX | 19,970 | -1.4% | 19.3% |
| NIKKEI 225 | 38,702 | -0.3% | 14.9% |
| S&P/ASX 200 INDEX | 8,067 | -1.2% | 7.0% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 69.04 | -0.49% |
| Brent Crude (ICE) | USD/bbl. | 72.54 | -0.47% |
| Gold Spot | USD/t oz. | 2,606 | 0.5% |
| Copper (Comex) | USd/lb. | 408 | 0.2% |
Click graph to enlarge
The UK 100 called to open -5 points at 8,100. The UK 100 looks set to open marginally lower this morning following yesterdays significant fall.
The Dow Jones narrowly snapped its longest losing streak since 1974 on Thursday. The 30-stock Dow added 15.37 points, or 0.04% to close at 42,342.24. The S&P slid 0.09% to 5,867.08, while the Nasdaq fell 0.10% to 19,372.77.
Asia-Pacific markets mostly fell on Friday as investors digest inflation data out of Japan, as well as an interest rate decision out of China. The People’s Bank of China held its loan prime rates steady on Friday, leaving the one-year rate unchanged at 3.1% and the five-year rate at 3.6%.
GSK today announced headline results from the FIRST-ENGOT-OV44 phase III trial evaluating Zejula (niraparib) and Jemperli (dostarlimab) in first line advanced ovarian cancer. The trial met its primary endpoint of PFS demonstrating a statistically significant difference with the addition of dostarlimab to both standard of care carboplatin-paclitaxel chemotherapy and niraparib maintenance, with or without bevacizumab.
No New Broker Comments
UK
None
US
None
UK
None
US
None
EU leaders summit
PBoC Interest Rate Decision
German Producer Price Index
UK Retail Sales
US Personal Consumption Expenditures
EU Consumer Confidence
Michigan Consumer Sentiment Index
UoM 5-year Consumer Inflation Expectation
UK 100 companies going ex-dividend on 24th December 2024:
BT Group
UK 250 companies going ex-dividend on 24th December 2024:
Schroder AsiaPacific Fund
JPMorgan Japanese Investment Trust
Global Smaller Companies Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.